Human2024-07-13
Anxiety and stress · CBG
Scientific reports · PMID 39003387
Double-blind placebo-controlled crossover field trial
- Studied preparation
- Single-batch CBG tincture also containing CBGA and terpenes.
- Population / model
- 34 healthy adults with prior cannabis-product experience; sessions were conducted remotely.
- What was observed
- Some self-reported anxiety and stress measures favored the tested formulation.
Interpretation limit
Small, acute field trial in a selected population; not a treatment trial for an anxiety disorder and not evidence for every CBG product.
Online publication · Source checked 2026-10-25
Sources, registration and terms
Citation and publication date recorded; peer-review/preprint status not separately classified.
PMC full-text link is recorded; current access and reuse rights are not verified here.
Registry state is a dated sponsor report; it does not confirm current recruitment or establish benefit.
- Results paper for this recorded registration
NCT05257044 registry context · Original NCT05257044
No results tables posted in registry
Status: Completed — sponsor-reported. Registry updated 2026-06-02; source checked 2026-10-25.
CBG / cannabigerol · Human study · Registered trial · Primary versus secondary outcome